Hepatitis B Virus Vaccines
New findings from Memorial Sloan-Kettering Cancer Center, Department of Pediatrics in the area of hepatitis b virus vaccines published
Published in Hepatitis Weekly, November 6th, 2006
Scientists discuss in "Immunogenicity of recombinant hepatitis B vaccine (rHBV) in recipients of unrelated or related allogeneic hematopoietic cell (HC) transplants" new findings in hepatitis B virus . "Current European and US guidelines for recombinant hepatitis B vaccine (rHBV) after hematopoietic-cell transplantation (HCT) vary. The European Group for Blood and Marrow Transplantation (EBMT) recommends rHBV starting 6 to 12 months after HCT," researchers in the United States report.
"Immunization is optional in the Centers for Disease Control and Prevention (CDC) guidelines. Nevertheless, rHBV is required for re-entry to school...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-11-06)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Hepatitis B virus adjuvant vaccine is immunologically ineffective after liver transplantation - Hepatitis C Virus
Acute hepatitis C virus infection involves transient immunological control - Hepatitis C Virus
Chronic hepatitis C fibrosis severity is associated with ABO blood group - Hepatitis C Virus
Hepatitis C virus replication inhibition evaluated by expressional screening - Hepatitis C Virus
High-affinity hepatitis C polymerase aptamers display genotypic specificity - Cholangio Cancer
Recent findings from Johns Hopkins University, Department of Pathology highlight research in cholangio cancer - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
